7 September 2020
The latest research findings from a team of modellers and epidemiologists at Oxford University’s Nuffield Department of Medicine and Google Research suggest digital contact tracing, such as that based on Google and Apple’s Exposure Notification System (ENS), can help to control the epidemic at low levels of app uptake.
7 September 2020
Oxford University researchers have found that natural infection with COVID-19 produces a robust T cell response, including inducing T cell ‘memory’ to potentially fight future infections.
19 August 2020
Ludwig Oxford's Dr Tammie Bishop organised a week of work experience for fifteen year 12 students in collaboration with the Magdalen Outreach Team. University Research Lecturer Dr Tammie Bishop works in the laboratory led by 2019 Nobel Prize-winning Sir Peter Ratcliffe (Target Discovery Institute & Ludwig Institute for Cancer Research) which conducts research into hypoxia, as well as currently being involved in research into the role of hypoxia in SARS-CoV-2.
Latest version of COVID-19 contact tracing app ready for testing on the Isle of Wight and Newham, London
14 August 2020
The Department of Health & Social Care announced the latest version of the contact tracing app will be tested on the Isle of Wight and with NHS volunteers from this week, and in the London Borough of Newham from next week. The app will enable you to report your symptoms and book a test directly through the app. If you test positive for COVID-19, your close proximity contacts from the last 2 weeks will be notified and advised to isolate to prevent onward spread of the virus.
4 August 2020
The Royal Society has today announced that it is awarding its Gabor Medal to David Stuart, who is Professor of Structural Biology in the Nuffield Department of Medicine and the Life Sciences Director of the Diamond Light Source, the National Synchrotron at Harwell. Professor Stuart is currently leading a large number of projects relating to the University’s response to COVID19, which include studying the structure of SARS-Cov-2 and a series of anti-viral drug discovery programmes. He is also leading the Oxford research team providing antibody immunity data on the UK population for the Office of National Statistics.
22 July 2020
A team of scientists at NDM’s Jenner Institute and The Oxford Vaccine Group has taken the next step towards the discovery of a safe, effective and accessible vaccine against coronavirus. The results of the Phase I/II trial published recently in the scientific journal, The Lancet, indicate no early safety concerns and induces strong immune responses in both parts of the immune system.
Oxford study suggests notable decline in coronavirus cases and R rate on Isle of Wight after launch of the test and trace programme
16 July 2020
team of epidemiologists, mathematical modellers and economists at NDM's Big Data Institute has released an independent analysis of the trends in the number of coronavirus infections (incidence) on the Isle of Wight, UK before and during the first phase of the test and trace programme (TT), including the first version of the NHS contact tracing app. Results of the study, which has not yet been subject to formal peer review, can be explored on EpiNow interactive tool.
14 July 2020
A generous gift of £3.5 million from Lakshmi Mittal and his family has secured the future of a critical professorship in vaccinology at the University. The post, which is currently held by NDM's Professor Adrian Hill, will be known as the Lakshmi Mittal and Family Professorship of Vaccinology in recognition of this support.
1 July 2020
Yang Shi has been appointed a Member of the Ludwig Institute for Cancer Research to continue his research into chromatin, RNA modifications and cancer. He joins NDM's Ludwig Institute from Harvard University, and is a world leader in the field of epigenetics, which explores how chemical modifications to chromatin—the combination of DNA and histone proteins—control the organisation and expression of the human genome.
25 June 2020
The Duke of Cambridge visits the University of Oxford’s Oxford Vaccine Centre, to learn more about their work to establish a viable vaccine against COVID-19. The Duke paid a visit to the Oxford Vaccine Centre facility at the Churchill Hospital in Oxford where the vaccine has been developed and trials are now underway. During his visit, The Duke was briefed about the Group’s work by NDM's Professor Sarah Gilbert, Professor of Vaccinology at the Jenner Institute, who developed the vaccine and Professor Andrew Pollard, Professor of Paediatric Infection and Immunity, who is leading the clinical trial team.
23 June 2020
Originally screened live on Friday 22nd May 2020, here is another chance to view the Vice-Chancellor, Professor Louise Richardson, being joined by Professor Richard Cornall, Head of the Nuffield Department of Medicine, to talk about the University's research into the COVID-19 virus.
1 May 2020
NDM's Dr Anita Milicic from the Jenner Institute, Old Road Campus Research Buillding and Dr Calliope Dendrou from the Wellcome Centre for Human Genetics, are part of a group with Professor Mark Coles from the Kennedy Institute who have received a share of $14 million in funding from the Chan Zuckerberg Initiative as one of 29 projects that will explore emerging ideas regarding the role of inflammation in disease.
30 April 2020
The University of Oxford has today announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the University.
23 April 2020
A team from NDM's Big Data Institute is sharing an epidemiological model to help configure a contact tracing app for coronavirus.
7 April 2020
The world’s largest randomised clinical trial of potential coronavirus treatments is well underway in the UK as part of the race to find a treatment.
31 March 2020
A team of medical researchers and bioethicists at Oxford University has published results today in Science that further our understanding of coronavirus transmission.
24 March 2020
The three projects include work on an effective vaccine, enabling pre-clinical and clinical vaccine trials, as well as supporting researchers to develop manufacturing processes to produce a vaccine at a million-dose scale.